Numinus CEO Payton Nyquvest Says Psychedelic Therapy Shouldn’t Be The ‘Last’ Option For Treatment Nov 21, 2021
Braxia CEO Dr. McIntyre Looks To Establish Framework For Psychedelic Therapeutic Advancement Nov 19, 2021
Synthesized Non-Hallucinogenic LSD Puts BetterLife Pharma on Psychedelic Investors Radar Nov 18, 2021
UCSF Releases Positive Report On Bucillamine’s Ability To Disrupt The Delta Variant And Protect Lungs In Vivo Nov 17, 2021
CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together” Nov 16, 2021
